x

Posted 14 April, 2023

Better Therapeutics, Inc. appointed new CEO

CEO Change detected for ticker Nasdaq:BTTX in a 8-K filed on 14 April, 2023.


  On April 10, 2023, Dr. Suying Liu notified Better Therapeutics, Inc., formerly Mountain Crest Acquisition Corp. II (the "Company") of his resignation as a member of the Company's board of directors, effective immediately. Dr. Liu was the Chairman and Chief Executive Officer of the special purpose acquisition company Mountain Crest Acquisition Corp. II prior to its business combination with and renaming as Better Therapeutics, Inc. in October 2021.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of Better Therapeutics, Inc.
Health Care/Life Sciences • Biotechnology
Better Therapeutics, Inc. operates as a digital therapeutics company, which engages in developing a novel form of cognitive behavioral therapy to address the root causes of cardio metabolic diseases. It offers software-based solutions for type 2 diabetes, heart disease and other conditions. The company was founded by Kevin J. Appelbaum and David P. Perry in April 2015 and is headquartered in San Francisco, CA.
Market Cap
$10.6M
View Company Details
Better Therapeutics, Inc. by TradingView
Relevant filing section
Item 5.02. 
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 


Director Resignation 

On April 10, 2023, Dr. Suying Liu notified Better Therapeutics, Inc., formerly Mountain Crest Acquisition Corp. II (the "Company") of his resignation as a member of the Company's board of directors, effective immediately. Dr. Liu was the Chairman and Chief Executive Officer of the special purpose acquisition company Mountain Crest Acquisition Corp. II prior to its business combination with and renaming as Better Therapeutics, Inc. in October 2021. He remained on the combined company's board of directors following the business combination until his resignation. Dr. Liu's resignation did not result from any disagreement with the Company or any person affiliated with the Company on any matter relating to the Company's operations, policies or practices.